The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
BIOAGE LABS INC COM 09077V100   13,352,992 3,233,170 SH   SOLE   3,233,170 0 0
BLOCK INC CL A 852234103   69,064,227 1,016,697 SH   SOLE   1,016,697 0 0
CAMP4 THERAPEUTICS CORP COM 13463J101   3,081,742 2,125,339 SH   SOLE   2,125,339 0 0
ERASCA INC COM 29479A108   3,635,375 2,862,500 SH   SOLE   2,862,500 0 0
GINKGO BIOWORKS HOLDINGS INC CL A NEW 37611X209   1,221,390 108,568 SH   SOLE   108,568 0 0
MAZE THERAPEUTICS INC COM 578784100   20,886,301 1,702,225 SH   SOLE   1,702,225 0 0
NAUTILUS BIOTECHNOLOGY INC COM 63909J108   12,797,324 17,653,917 SH   SOLE   17,653,917 0 0
OMADA HEALTH INC COM 68170A108   84,446,704 4,614,574 SH   SOLE   4,614,574 0 0
OPENDOOR TECHNOLOGIES INC COM 683712103   3,305,038 6,200,821 SH   SOLE   6,200,821 0 0
REVOLUTION MEDICINES INC COM 76155X100   101,118,161 2,748,523 SH   SOLE   2,748,523 0 0